Rankings
▼
Calendar
MLTX FY 2020 Earnings — MoonLake Immunotherapeutics Revenue & Financial Results | Market Cap Arena
MLTX
MoonLake Immunotherapeutics
$1B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$105,755
Net Income
-$90,838
EPS (Diluted)
$-0.01
Cash Flow
Operating Cash Flow
-$316,692
Free Cash Flow
-$316,692
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$117M
Total Liabilities
$4M
Stockholders' Equity
$112M
Cash & Equivalents
$1M
← Q4 2020
All Quarters
